Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DCL000530

Drug Information
NameGabapentin enacarbil
SynonymsCyclohexaneacetic acid, 1-((((1-(2-methyl-1-oxopropoxy)ethoxy)carbonyl)amino)methyl)-; XP-13512; GSK-1838262; Solzira; UNII-75OCL1SPBQ; Gabapentin enacarbil; XP 13512; D09539; XP13512; 478296-72-9; XP-053; 791632-57-0; ASP-8825; CID9883933; Horizant; Gabapentin enacarbil (JAN/USAN/INN)
IndicationMigraine prophylaxis and neuropathic pain
[ICD9: 338, 346,780   ICD10: G43, R52, G89]
Phase II    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC(C)C(=O)OC(C)OC(=O)NCC1(CCCCC1)CC(=O)O    
Therapeutic ClassAnalgesics
CAS NumberCAS 478296-72-9
PubChem Compound IDCID 9883933.
PubChem Substance IDSID 14850951.
TargetVoltage-gated calcium channel subunit alpha Modulator[1]
Ref 1GSK. Product Development Pipeline. February 2009. To Reference


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543